Novus Biologicals products are now on bio-techne.com

RelA/NFkB p65 [p Ser529, p Ser536] Inhibitor Peptide Set

Images

 
Western Blot: RelA/NFkB p65 [p Ser529, p Ser536] Inhibitor Peptide Set [NBP2-29321] - Inhibits TNF-induced NF-kB activation: KBM-5 cells were incubated with various concentrations of peptides for 1 hr and treated with ...read more
Western Blot: RelA/NFkB p65 [p Ser529, p Ser536] Inhibitor Peptide Set [NBP2-29321] - Effect of various p65-inhibitor peptides on binding of purified recombinant p65 protein to the DNA in vitro. Recombinant p65 protein ...read more
Functional (Inhibition): RelA/NFkB p65 [p Ser529, p Ser536] Inhibitor Peptide Set [NBP2-29321] - TLR5/NF-kB/SEAPorter HEK 293 (NBP2-26277) cells were plated in 96-well plates at 5 x 10^4 cells/well for 16 h. Cells were ...read more

Product Details

Summary
Reactivity Hu, Mu, Rt, Bv, CaSpecies Glossary
Concentration
LYOPH

Order Details

Novus Biologicals is part of Bio-Techne

Shop this product on bio-techne.com

RelA/NFkB p65 [p Ser529, p Ser536] Inhibitor Peptide Set Summary

Immunogen
Functions as a p65 decoy through phosphorylation of the Ser529/536 sites on the peptide.
Modification
p Ser529, p Ser536
Preparation
Method
Preparation of 5 mM Stock Solutions
PBS* is added directly to the vials to prepare the stock solutions.
Note: Bring the solution to room temperature and quick spin the tubes before opening the caps. NF-kB p65(Ser529/536) Inhibitor Peptide: 1mg of DRQIKIWFQNRRMKWKKNGLLSGDEDFSS
Add 54.1 ul PBS* to the vial, to make a 5 mM stock solution. Mix by vortexing. Aliquot and store at -20C or -80C. Avoid repeated freeze thawing.

Control Peptide: 1 mg of DRQIKIWFQNRRMKWKK
Add 84.8 ul PBS* to the vial. Mix by vortexing. Aliquot and store at -20C or -80C. Avoid repeated freeze thawing.
*Recipe for 1X PBS:
1. Dissolve the following in 800ml distilled H2O.
- 8g of NaCl
- 0.2g of KCl
- 1.44g of Na2HPO4
- 0.24g of KH2PO4
2. Adjust pH to 7.5 with HCl.
3. Adjust volume to 1L with additional distilled H2O.
4. Sterilize by autoclaving
Content
Inhibitor peptide (NBP2-31224): 2 x 1 mg (lyophilized) DRQIKIWFQNRRMKWKKNGLLSGDEDFSS (p65 sequence: NGLLSGDEDFSS). Molecular weight: 3697.21 Antennapedia Control peptide (NBP2-29334): 2 x 1 mg (lyophilized) DRQIKIWFQNRRMKWKK. Molecular weight: 2361
Gene
RELA

Applications/Dilutions

Application Notes
Inhibition of NF-kB activitiy.

Researchers can study the effect of p65 inhibitor peptide using a variety of methods. Following is a general protocol for KBM-5 cells. It may need to be optimized for different cell types.

Preincubate cells with appropriate amounts of inhibitory or control peptides for 1 hr and then treat with TNF or other NF-kB activating agents. Prepare nuclear extracts and check for the presence of NF-kB DNAbinding activity by EMSA (Figure 1). Nuclear extracts can be prepared as described by Bharati A, et al, 2003 and Takada et al, 2004 or using nuclear extraction kit.

Please refer to Takada et al, 2004 for further details on the use of this inhibitory peptide.
Publications
Read Publications using NBP2-29321.

Reactivity Notes

Broad: Peptide sequence is 100% conserved across multiple species.

Packaging, Storage & Formulations

Storage
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Concentration
LYOPH
Reconstitution Instructions
Please contact technical support for detailed reconstitution instructions.

Alternate Names for RelA/NFkB p65 [p Ser529, p Ser536] Inhibitor Peptide Set

  • MGC131774
  • nf kb inhibitor
  • nf kb p65 inhibitor
  • nf kb p65
  • nfkb inhibitor
  • nfkb p65 inhibitor
  • NFkB p65
  • NF-kB p65
  • NFKB3
  • NFKB3v-rel avian reticuloendotheliosis viral oncogene homolog A (nuclear factor ofkappa light polypeptide gene enhancer in B-cells 3 (p65))
  • Nuclear factor NF-kappa-B p65 subunit
  • Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3transcription factor p65
  • p65 inhibitor
  • p65
  • p65RelA
  • rela inhibitor
  • rela p65
  • RelA
  • v-rel reticuloendotheliosis viral oncogene homolog A (avian)
  • v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappalight polypeptide gene enhancer in B-cells 3, p65

Background

NF-kB has been shown to regulate the expression of a number of genes whose products are involved in inflammation, viral replication, carcinogenesis, anti-apoptosis, invasion, and metastasis. Specific adhesion molecules, chemokines, inflammatory cytokines, and cell cycle regulatory genes are affected. Thus, agents that can suppress NF-kB activation have the potential to be treatments for inflammatory diseases and cancer.

The Ser529/536 sites of p65 are phosphorylated during NF-kB activation, allowing p65 nuclear translocation. This p65 inhibitory peptide contains Ser529/536 sites that are phosphorylated during NF-kB activation, thereby blocking p65 Ser529/536 phosphorylation. The NF-kB p65(Ser529/536) Inhibitor Peptide can inhibit binding of recombinant p65 protein to the DNA in a dose dependent manner and maximum inhibition occurs at 50 uM (Figure 1). It can also inhibit TNF-induced NF-kB activation in cells (See Figure 2)

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Inhibitors are guaranteed for 1 year from date of receipt.

Customers Who Viewed This Item Also Viewed...

NB100-56583
Species: Hu, Rb, Rt
Applications: Flow, IHC, IHC-P, KO, WB
AF632
Species: Hu
Applications: AgAct, Simple Western, WB
NBP1-88650
Species: Hu
Applications: IHC, IHC-P, KD, WB
NBP2-01345
Species: Hu, Mu, Rt
Applications: Flow, ICC/IF, IHC, IHC-P, WB
M6000B
Species: Mu
Applications: ELISA
AF2699
Species: Mu
Applications: Simple Western, WB
MAB8930
Species: Hu
Applications: ICC, Simple Western, WB
NB100-56507
Species: Hu, Mu, Rt
Applications: CyTOF-ready, Flow, ICC/IF, IHC, IHC-P, IP, KO, Simple Western, WB
NB300-605
Species: Hu, Mu, Po, Rt
Applications: Flow, IB, ICC/IF, IHC, IHC-Fr, IHC-P, In vitro, WB
AF1230
Species: Hu, Mu, Rt
Applications: IHC, KO, WB
NB100-689
Species: Hu, Rt
Applications: IHC, IHC-Fr, IHC-P, Simple Western, WB
NBP2-50037
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, KO, WB
AF3235
Species: Hu, Mu, Rt
Applications: IHC, WB
MAB208
Species: Hu
Applications: CyTOF-ready, ELISA(Cap), ELISA(Det), ELISA(Sta), ICC, ICFlow, Neut, Simple Western, WB
NBP1-87760
Species: Hu
Applications: ICC/IF, IHC, IHC-P, KD, Simple Western, WB
NBP2-47415
Species: Hu
Applications: ICC/IF, IHC, IHC-P, WB
AF887
Species: Hu, Mu, Rt
Applications: CyTOF-ready, IHC, ICFlow, Simple Western, WB
NBP2-22203
Species: Hu, Pm, Mu, Rt
Applications: ELISA, Flow, ICC/IF, IHC, IHC-P, WB
MAB17761
Species: Hu, Mu, Rt
Applications: ICC, WB
Supplier Logo

Publications for RelA/NFkB p65 Inhibitor (NBP2-29321)(13)

We have publications tested in 2 confirmed species: Human, Mouse.


Filter By Application
All Applications
Filter By Species
Human
(2)
Mouse
(4)
All Species
Showing Publications 1 - 10 of 13. Show All 13 Publications.
Publications using NBP2-29321 Applications Species
Almarghlani A, Settem RP, Croft AJ et al. Interleukin-34 permits Porphyromonas gingivalis survival and NF-?B p65 inhibition in macrophages Molecular Oral Microbiology 2022-06-01 [PMID: 35576119]
Sherman LS, Patel SA, Castillo MD Et al. Nf kappa B Targeting in Bone Marrow Mesenchymal Stem Cell-Mediated Support of Age-Linked Hematological Malignancies Stem cell reviews and reports 2021-08-19 [PMID: 34410592]
Yang D, Li S, Duan X TLR4 induced Wnt3a-Dvl3 restrains the intensity of inflammation and protects against endotoxin-driven organ failure through GSK3beta/beta-catenin signaling Mol. Immunol. 2019-12-26 [PMID: 31884387] (Human, Mouse) Human, Mouse
Yu J, Berga SL, Zou W et al. IL-1B Inhibits Connexin 43 and Disrupts Decidualization of Human Endometrial Stromal Cells through ERK1/2 and p38 MAP Kinase Endocrinology 2017-09-11 [PMID: 28938400]
Mukohda M, Lu KT, Guo DF et al. Hypertension-Causing Mutation in Peroxisome Proliferator-Activated Receptor y Impairs Nuclear Export of Nuclear Factor-kB p65 in Vascular Smooth Muscle. Hypertension 2017-05-15 [PMID: 28507170] (Mouse) Mouse
Mukohda M, Stump M, Ketsawatsomkron P et al. Endothelial PPARy Provides Vascular Protection from IL-1B-Induced Oxidative Stress. Am. J. Physiol. Heart Circ. Physiol. 2015-11-13 [PMID: 26566726]
Golden D, Saria EA, Hansen MF. Regulation of Osteoblast Migration Involving Receptor Activator of Nuclear Factor (NF)-Kappa B (RANK) Signaling J. Cell. Physiol. 2015-04-20 [PMID: 25893522]
Qiao Hongwen, Zhu Lin, Lieberman Brian P et al. Synthesis and evaluation of novel tropane derivatives as potential PET imaging agents for the dopamine transporter. Bioorg Med Chem Lett. 2012-07-01 [PMID: 22658558]
Rajasekaran V. Tissue Transglutaminase (TG2) is a potential therapeutic target in the treatment of chemoresistant breast cancer. Breast Cancer Res 2012-01-10 [PMID: 22225906]
Li J, Liu Y, Zhang X. Murine coronavirus induces type I interferon in oligodendrocytes through recognition by RIG-I and MDA5. J Virol. 2010-07-01 [PMID: 20427526] (Mouse)

Details:
Functional Assay (TransAM ELISA): N20.1 cell line (mouse oligodendrocytes) infected with MHV-A59/GFP virus, Fig 7B, 7C, and 7D.Fig 7B, Readout assay: NFkB activation. Cells treated with NF-kB p65 inhibitory peptide (IMG-2003) showed significant inhibition
Mouse
Show All 13 Publications.

Reviews for RelA/NFkB p65 Inhibitor (NBP2-29321) (0)

There are no reviews for RelA/NFkB p65 Inhibitor (NBP2-29321). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

Product General Protocols

View specific protocols for RelA/NFkB p65 Inhibitor (NBP2-29321): Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs for RelA/NFkB p65 Inhibitor (NBP2-29321) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Additional RelA/NFkB p65 Products

Research Areas for RelA/NFkB p65 Inhibitor (NBP2-29321)

Find related products by research area.

Blogs on RelA/NFkB p65.

Killing two birds with one stone: Treating inflammation and cancer by inhibiting prolyl-4-hydroxylase-1
By Jamshed Arslan Pharm.D. The cell’s oxygen-sensing machinery comprises prolyl-4-hydroxylases (P4Hs 1-3, PHDs 1-3, or EGLN 1-3) and their canonical target hypoxia-inducible factors (HIFs). When oxygen levels ...  Read full blog post.

The effect of antioxidants and the NFkB p65 pathway in inflammation
NFkB is a transcription factor that plays a role in the expression of genes involved in immune response, inflammation, metastasis, cell survival and more. RelA (p65) is one member of the NFkB mammalian family, alongside other subunits. NFkB subunit...  Read full blog post.

NFkB3-p65: Say that three times fast!
NF-kappa-B is a ubiquitous transcription factor involved in several biological processes such as inflammation, immunity, differentiation, cell growth, tumor genesis and apoptosis. Unlike the majority of transcription factors that reside in the nucleus...  Read full blog post.

Read our latest blog and use the new citation tool on bio-techne.com

Customers Who Bought This Also Bought

Contact Information

Product PDFs

Review this Product

Be the first to review our RelA/NFkB p65 [p Ser529, p Ser536] Inhibitor Peptide Set and receive a gift card or discount.

Bioinformatics

Gene Symbol RELA